Results 171 to 180 of about 772,849 (300)

Selective Inhibition of Tumor Necrosis Factor for Attenuating Alzheimer's Disease: Strategies Targeting Neuroinflammation. [PDF]

Inflammation
Udaiyappan JP, Balakrishnan R, Tamilarasan MM, Balasubramanian B, Abass KS.   +4 more
europepmc   +1 more source

Hydrogel‐Based Airway‐on‐Tube With Perfusable Endothelial Lumen and Outward Epithelialization

Advanced Materials, EarlyView.
A hydrogel‐based airway‐on‐tube platform featuring a perfusable endothelial lumen and outward epithelialization is presented. The system supports primary human bronchial epithelial and lung microvascular endothelial coculture under air‐liquid interface conditions.
Ali Doryab, Jack F. Murphy, Michael Bartolf‐Kopp, Jenny C‐C Hsin, Alice Chernaik, Frank McCaughan, Yan Yan Shery Huang, Tomasz Jungst, Jürgen Groll   +8 more
wiley   +1 more source

Tumor Microenvironment Onmyoji: Cytokines with Dual Protumor and Antitumor Roles. [PDF]

Cancer Commun (Lond)
Wang Y, Lin A, Liu Z, Cheng Q, Zhang J, Luo P.   +5 more
europepmc   +1 more source

Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Proceedings of the National Academy of Sciences of the United States of America, 1991
Martyn Lewis, L. Tartaglia, Angela L. Lee, G. Bennett, G. Rice, G. Wong, E. Chen, D. Goeddel   +7 more
semanticscholar   +1 more source

Architecture of an All‐In‐One Microfluidic Platform for Accelerated Cancer Seeding, Enhanced Spheroid Formation, and Dynamic Drug Screening Trials

Advanced Materials Technologies, EarlyView.
An all‐in‐one microfluidic platform consists of two‐layered PDMS channels integrated with a hydrogel microwell array. This platform enables flow‐driven tumor cell capture, enhanced spheroid formation within the microwells, and advective drug testing. ABSTRACT Effective cancer drug screening requires platforms that replicate the physiological complexity
Omar M. Rahman, Shengxi Lan, Dae Kun Hwang   +2 more
wiley   +1 more source

Interest of PD-L1 in the management of triple negative breast cancers in Ivorian patients. [PDF]

BMC Womens Health
Diallo A, Aman NA, Traore B, Coulibaly ZI, Kouacou BFA, Nzi MR, Doukoure B, Diomande MI.   +7 more
europepmc   +1 more source

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Proceedings of the National Academy of Sciences of the United States of America, 1989
Laurelee Osborn, S. Kunkel, G. Nabel
semanticscholar   +1 more source

End‐to‐End Sensing Systems for Breast Cancer: From Wearables for Early Detection to Lab‐Based Diagnosis Chips

Advanced Materials Technologies, EarlyView.
This review explores advances in wearable and lab‐on‐chip technologies for breast cancer detection. Covering tactile, thermal, ultrasound, microwave, electrical impedance tomography, electrochemical, microelectromechanical, and optical systems, it highlights innovations in flexible electronics, nanomaterials, and machine learning.
Neshika Wijewardhane, Lyn I. Jones, Richard M. Martin, Helen Winter, Faezeh Arab Hassani   +4 more
wiley   +1 more source

Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy. [PDF]

Front Immunol
Zhang R, Ma P, Tang K, Cao Y, Yang Y, Hao S, Li T, Peng X.   +7 more
europepmc   +1 more source

Microfluidic Hydroporation Platform for Effective Allogeneic CAR‐T Cell Production and Subsequent Functional Cytotoxicity Analysis

Advanced Materials Technologies, EarlyView.
The hydroporator platform employs controlled hydrodynamic deformation for efficient mRNA and CRISPR/Cas9 delivery into primary human T cells, enabling allogeneic CAR‐T cell manufacturing. It preserves cell functionality and drives potent gene editing, CAR expression, and tumor cytotoxicity, while feature‐based analysis links these functional outcomes ...
Soohyun Jeon, Sein Kim, Hyun‐Young Kim, Duck Cho, Sungsu Park, Seohyun Kim, Aram J. Chung   +6 more
wiley   +1 more source